Sign in
4

Changes in Ownership

Seres Therapeutics, Inc. Filed Acc 0000899243-22-025509

CEO and President acquired 63,492 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Shaff Eric D. · CEO and President

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2022-07-05 Grant or award : show line 1 in the form +63,492 $3.15 $200,000 96,334 D
Loading xslF345X03/doc4.xml…